Education
About Us
Working with TipRanks
Follow Us
cbdMD (YCBD)
:YCBD
YCBD Stock Chart & Stats
$2.27
>-$0.01(-0.46%)
At close: 4:00 PM EST
$2.27
>-$0.01(-0.46%)
Day’s Range― - ―
52-Week Range$0.47 - $6.54
Previous CloseN/A
Volume938.08K
Average Volume (3M)7.54M
Market Cap
$12.75M
Enterprise Value$5.06M
Total Cash (Recent Filing)$1.06M
Total Debt (Recent Filing)$962.74K
Price to Earnings (P/E)―
Beta0.45
Next Earnings
Dec 19, 2025EPS Estimate
-0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding8,919,410
10 Day Avg. Volume860,286
30 Day Avg. Volume7,543,844
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)8.26
Price to Sales (P/S)0.83
P/FCF Ratio-25.23
Enterprise Value/Market Cap0.40
Enterprise Value/Revenue0.27
Enterprise Value/Gross Profit0.43
Enterprise Value/Ebitda30.12
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Distribution ExpansionHerbal Oasis, YCBD's hemp-derived THC beverage brand, recently expanded distribution into Tennessee and Minnesota, with product availability in these markets expected.
Financial FlexibilityThe successful conversion of Series A preferred stock into common equity is seen as a significant milestone, enhancing financial flexibility by eliminating all accrued and future dividend obligations.
Bears Say
Earnings MissF3Q25 results missed expectations, reflecting ongoing softness in retail demand for CBD products.
Regulatory ChallengesOngoing softness in retail demand for CBD products is further pressured by state-level regulatory changes and proposals that have heightened uncertainty across the broader cannabinoid retail market and weighed on wholesale performance.
cbdMD News
YCBD FAQ
What was cbdMD’s price range in the past 12 months?
cbdMD lowest stock price was $0.47 and its highest was $6.54 in the past 12 months.
What is cbdMD’s market cap?
cbdMD’s market cap is $12.75M.
When is cbdMD’s upcoming earnings report date?
cbdMD’s upcoming earnings report date is Dec 19, 2025 which is today.
How were cbdMD’s earnings last quarter?
cbdMD released its earnings results on Aug 14, 2025. The company reported -$0.21 earnings per share for the quarter, missing the consensus estimate of -$0.02 by -$0.19.
Is cbdMD overvalued?
According to Wall Street analysts cbdMD’s price is currently Overvalued.
Does cbdMD pay dividends?
cbdMD does not currently pay dividends.
What is cbdMD’s EPS estimate?
cbdMD’s EPS estimate is -0.07.
How many shares outstanding does cbdMD have?
cbdMD has 8,919,410 shares outstanding.
What happened to cbdMD’s price movement after its last earnings report?
cbdMD reported an EPS of -$0.21 in its last earnings report, missing expectations of -$0.02. Following the earnings report the stock price went down -10.588%.
Which hedge fund is a major shareholder of cbdMD?
Currently, no hedge funds are holding shares in YCBD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
cbdMD
cbdMD (YCBD) is a leading provider of CBD (cannabidiol) products, focusing on the wellness sector. The company offers a diverse range of products, including tinctures, topicals, gummies, and pet products, all derived from hemp. cbdMD aims to provide high-quality, third-party tested CBD products that promote health and wellness, targeting both human and animal consumers. With a strong emphasis on branding and customer education, the company positions itself as a trusted resource in the rapidly growing CBD industry.
YCBD Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted successful capital restructuring and cost reductions, along with growth in wholesale revenue and an award-winning product launch. However, challenges include a decrease in total net sales, flat e-commerce revenue, and a negative working capital position.View all YCBD earnings summariesTechnical Analysis
Tilray
―
SNDL
―
IM Cannabis Corp
―
Flora Growth
―
Incannex Healthcare Limited Sponsored ADR
―
Ownership Overview
12.72% Insiders
0.59% Mutual Funds
4.04% Other Institutional Investors
82.09% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---